Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Gangwal Healthcare? Find Betrixaban Maleate to address your drug delivery challenges on PharmaCompass.

Betrixaban Maleate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 1 USDMF, 1 NDC API, 8 Listed Suppliers

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 40MG, CAPSULE;ORAL - 80MG

RELATED EXCIPIENT COMPANIES

7 DKSH, 1 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 4 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 DFE Pharma, 1 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Lonza Capsugel, 5 Microlex e.U, 2 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Fillers, Diluents & Binders, 9 Disintegrants & Superdisintegrants, 8 Lubricants & Glidants, 8 Empty Capsules, 5 Coating Systems & Additives, 5 Thickeners and Stabilizers, 3 Coloring Agents, 2 Granulation, 2 Direct Compression, 2 Parenteral, 2 Film Formers & Plasticizers, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Emulsifying Agents, 1 Taste Masking, 1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

Xls

Filters

Betrixaban Maleate

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Gangwal Healthcare

filter Capability Reset all filters

filter Country Reset all filters

01

Gangwal Healthcare

India

CPhI India 2024

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : DiCOM-DC® SR300

Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Brand : DICOM-DC® SR300

Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

Gangwal Healthcare DiCOM-DC® SR300

Excipients Web Link

Digital Content

02

Gangwal Healthcare

India

CPhI India 2024

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : Sallyso™

Application : Disintegrants & Superdisintegrants

Excipient Details : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Ingredient(s) : Croscarmellose Sodium

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : Croscarmellose Sodium

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Disintegrants & Superdisintegrants

Brand : SALLYSO™

Applications : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Grade : Oral

Gangwal Healthcare Sallyso™

Excipients Web Link

Digital Content